Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STZ.B
2151
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $1.85M | ﹤0.01% |
8,700
| – | – |
|
|
MMX
2152
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $1.84M | ﹤0.01% |
411,547
+97,147
| +31% | +$464K |
|
|
QUMU
2153
DELISTED
Qumu Corp.
QUMU
| $1.83M | ﹤0.01% |
738,756
-316,698
| -30% | -$840K |
|
|
AATC
2154
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $1.83M | ﹤0.01% |
248,149
-9,628
| -4% | -$68.8K |
|
2155
Encore Capital Group
ECPG
$2.2B
| $1.83M | ﹤0.01% |
37,105
+12,700
| +52% | +$603K |
|
2156
iShares MSCI Saudi Arabia ETF
KSA
$624M
| $1.83M | ﹤0.01% |
43,700
+30,100
| +221% | +$1.22M |
|
2157
OP Bancorp
OPBK
$233M
| $1.83M | ﹤0.01% |
177,400
-64,200
| -27% | -$653K |
|
2158
Donaldson
DCI
$11.1B
| $1.83M | ﹤0.01% |
+31,800
| New | +$2.05M |
|
2159
Essent Group
ESNT
$6.25B
| $1.82M | ﹤0.01% |
+41,400
| New | +$1.88M |
|
2160
The ONE Group
STKS
$57.8M
| $1.81M | ﹤0.01% |
169,800
+24,326
| +17% | +$251K |
|
2161
iShares Russell 1000 ETF
IWB
$50.4B
| $1.81M | ﹤0.01% |
+7,500
| New | +$1.86M |
|
|
LFC
2162
DELISTED
China Life Insurance Company Ltd.
LFC
| $1.81M | ﹤0.01% |
222,000
-743,931
| -77% | -$6.37M |
|
|
SBT
2163
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $1.81M | ﹤0.01% |
350,106
-86,558
| -20% | -$434K |
|
2164
Lightpath Technologies
LPTH
$953M
| $1.8M | ﹤0.01% |
847,370
-205,255
| -19% | -$454K |
|
2165
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
| $1.8M | ﹤0.01% |
26,726
-178,082
| -87% | -$12.1M |
|
|
MLVF
2166
DELISTED
Malvern Bancorp, Inc.
MLVF
| $1.8M | ﹤0.01% |
106,264
-3,100
| -3% | -$56.1K |
|
|
KOR
2167
DELISTED
Corvus Gold Inc. Common Shares
KOR
| $1.8M | ﹤0.01% |
+565,765
| New | +$1.76M |
|
2168
Citius Pharmaceuticals
CTXR
$20.7M
| $1.8M | ﹤0.01% |
35,540
-40,394
| -53% | -$2.03M |
|
|
DCH
2169
Dauch Corp
DCH
$1.6B
| $1.8M | ﹤0.01% |
204,124
-402,275
| -66% | -$3.69M |
|
|
CODX
2170
Co-Diagnostics
CODX
$5.16M
| $1.79M | ﹤0.01% |
6,150
+4,107
| +201% | +$1.2M |
|
2171
Amdocs
DOX
$6.18B
| $1.79M | ﹤0.01% |
+23,700
| New | +$1.83M |
|
2172
Flanigan's Enterprises
BDL
$90.1M
| $1.78M | ﹤0.01% |
66,900
+8,200
| +14% | +$231K |
|
2173
Team
TISI
$101M
| $1.78M | ﹤0.01% |
59,306
+26,803
| +82% | +$1.29M |
|
2174
Cumberland Pharmaceuticals
CPIX
$117M
| $1.78M | ﹤0.01% |
664,564
-36,899
| -5% | -$110K |
|
2175
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $1.78M | ﹤0.01% |
37,500
+8,400
| +29% | +$407K |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.